Skip to main content

Ilda Bidollari, MD, MBA

Objective: Evaluate safety and tolerability of an aripiprazole lauroxil (AL) 2-month regimen using 1-day initiation in patients hospitalized for acute exacerbation of schizophrenia and tr...
10/08/2020